FDA Clears First OTC Continuous Glucose Monitor for Children
The FDA approved Dexcom Inc.'s Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor for children ages 2 and older who don't use insulin. The integrated CGM device can now be marketed directly to consumers without prescription.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day